| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Geron Corporation (NASDAQ: GERN)
GERN Technical Analysis
5
| As on 26th Feb 2025 GERN STOCK Price closed @ 1.61 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.91 & Strong Sell for SHORT-TERM with Stoploss of 1.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GERNSTOCK Price
| Open | 1.73 | Change | Price | % |
| High | 1.77 | 1 Day | -0.76 | -32.07 |
| Low | 1.46 | 1 Week | -0.95 | -37.11 |
| Close | 1.61 | 1 Month | -1.37 | -45.97 |
| Volume | 93325831 | 1 Year | -0.73 | -31.20 |
| 52 Week High 5.09 | 52 Week Low 1.74 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 131.28 | 3.67% |
| LCID | 2.25 | -13.79% |
| SMCI | 51.11 | 12.23% |
| ENVB | 2.30 | 94.92% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| TSLA | 290.80 | -3.96% |
| ADTX | 0.08 | 0.00% |
| GERN | 1.61 | -32.07% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GERN Daily Charts |
GERN Intraday Charts |
Whats New @ Bazaartrend |
GERN Free Analysis |
|
|
GERN Important Levels Intraday
| RESISTANCE | 2.21 |
| RESISTANCE | 2.02 |
| RESISTANCE | 1.90 |
| RESISTANCE | 1.78 |
| SUPPORT | 1.44 |
| SUPPORT | 1.32 |
| SUPPORT | 1.20 |
| SUPPORT | 1.01 |
GERN Forecast February 2025
| 4th UP Forecast | 2.36 |
| 3rd UP Forecast | 2.12 |
| 2nd UP Forecast | 1.97 |
| 1st UP Forecast | 1.82 |
| 1st DOWN Forecast | 1.4 |
| 2nd DOWN Forecast | 1.25 |
| 3rd DOWN Forecast | 1.1 |
| 4th DOWN Forecast | 0.86 |
GERN Weekly Forecast
| 4th UP Forecast | 2.05 |
| 3rd UP Forecast | 1.91 |
| 2nd UP Forecast | 1.82 |
| 1st UP Forecast | 1.74 |
| 1st DOWN Forecast | 1.48 |
| 2nd DOWN Forecast | 1.40 |
| 3rd DOWN Forecast | 1.31 |
| 4th DOWN Forecast | 1.17 |
GERN Forecast2025
| 4th UP Forecast | 9.09 |
| 3rd UP Forecast | 6.69 |
| 2nd UP Forecast | 5.21 |
| 1st UP Forecast | 3.72 |
| 1st DOWN Forecast | -0.5 |
| 2nd DOWN Forecast | -1.99 |
| 3rd DOWN Forecast | -3.47 |
| 4th DOWN Forecast | -5.87 |
Geron Corporation ( NASDAQ USA Symbol : GERN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GERN Business Profile
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California. Address: 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service